Effectiveness and safety of long-term treatment with sulfonylureas in patients with neonatal diabetes due to KCNJ11 mutations: an international cohort study

BACKGROUND: KCNJ11 mutations cause permanent neonatal diabetes through pancreatic ATP-sensitive potassium channel activation. 90% of patients successfully transfer from insulin to oral sulfonylureas with excellent initial glycaemic control; however, whether this control is maintained in the long ter...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Lancet Diabetes Endocrinol
Главные авторы: Bowman, Pamela, Sulen, Åsta, Barbetti, Fabrizio, Beltrand, Jacques, Svalastoga, Pernille, Codner, Ethel, Tessmann, Ellen H, Juliusson, Petur B, Skrivarhaug, Torild, Pearson, Ewan R, Flanagan, Sarah E, Babiker, Tarig, Thomas, Nicholas J, Shepherd, Maggie H, Ellard, Sian, Klimes, Iwar, Szopa, Magdalena, Polak, Michel, Iafusco, Dario, Hattersley, Andrew T, Njølstad, Pål R
Формат: Artigo
Язык:Inglês
Опубликовано: The Lancet, Diabetes & Endocrinology 2018
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6058077/
https://ncbi.nlm.nih.gov/pubmed/29880308
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S2213-8587(18)30106-2
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы